Asthma control and management changes in Japan: Questionnaire survey

Internal Medicine

Volumn 51, Issue 6, 2012, Pages 567-574

  Hasegawa, Takashi ^a   Koya, Toshiyuki ^b   Sakagami, Takuro ^b   Toyabe, Shinichi ^a   Kagamu, Hiroshi ^b   Arakawa, Masaaki ^b   Gejyo, Fumitake ^b   Narita, Ichiei ^b   Suzuki, Eiichi ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Asthma; Control; Inhaled corticosteroid; Questionnaire survey

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE; TULOBUTEROL;

ADULT; AGE; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; DEATH; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; JAPAN; MALE; PRACTICE GUIDELINE; QUESTIONNAIRE; UNCONSCIOUSNESS; VENTILATOR;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE MANAGEMENT; EMERGENCIES; FEMALE; FORECASTING; HEALTH SURVEYS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; JAPAN; MALE; MIDDLE AGED; MORBIDITY; PATIENTS; QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84858216959     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6586     Document Type: Article

References (27)

1. Hasegawa T, Suzuki E, Terada M, et al. Improvement of asthma management in actual practice consistent with prevalence of anti-inflammatory agents: Based on questionnaire surveys in Niigata Prefecture, Japan from 1998 to 2002. Allergol Int 54: 555-563, 2005.
2. Hasegawa T, Suzuki E, Muramatsu Y, et al. Questionnaire-based analysis of the current level of asthma control and management in Niigata Prefecture, Japan: Changes from 1998 to 2000. Allergol Int 53: 145-151, 2004.
3. Ohta K, Yamaguchi M, Akiyama K, et al. Japanese guideline for adult asthma. Allergol Int 60: 115-145, 2011.
4. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478, 2004.
5. Lai CK, De Guia TS, Kim YY, et al; Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma control in the Asia- Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 111: 263-268, 2003.
6. Weiss KB, Sullivan SD. The economic costs of asthma: a review and conceptual model. Pharmacoeconomics 41: 14-30, 1993.
7. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary Report 2007. J Allergy Clin Immunol 120 (suppl): S94-S138, 2007.
8. Kroegel C. Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 5: 239-249, 2009.
9. Suzuki E, Hasegawa T, Koya T, et al. Questionnaire-based analysis of current status of adult bronchial asthma in Niigata Prefecture. Comparison with the Asthma Guideline. Acta Medica Biologica 50: 135-143, 2002.
10. Suzuki E, Hasegawa T, Koya T, et al. Questionnaire-based characterization of bronchial asthma in elderly. Analysis in Niigata Prefecture, Japan. Allergol Int 51: 241-248, 2002.
11. Yoshimine F, Hasegawa T, Suzuki E, et al. Contribution of aspirin intolerant asthma to near fatal asthma based on questionnaire surveys in Niigata Prefecture, Japan. Respirology 10: 477-484, 2005.
12. Suzuki K, Hasegawa T, Sakagami T, et al. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int 56: 249-255, 2007.
13. Koyanagi K, Koya T, Sasagawa M, et al. An analysis of factors that exacerbate asthma, based on a Japanese questionnaire. Allergol Int 58: 519-527, 2009.
14. Ota K, Hasegawa T, Koya T, et al. Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire - Effects of age, gender, and disease severity. Allergol Int 58: 365-371, 2009.
15. Satoh H, Hasegawa T, Suzuki E, et al. Gender differences in susceptibility of asthma to active smoking. Questionnaire based analysis in the Niigata Prefecture, Japan. Allergol Int 54: 401-410, 2005.
16. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113: 59-65, 2004.
17. Sato R, Tomita K, Sano H, et al. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test. J Asthma 46: 677-682, 2009.
18. Shirai T, Furuhashi K, Suda T, Chida K. Relationship of the asthma control test with pulmonary function and exhaled nitric oxide. Ann Allergy Asthma Immunol 101: 608-613, 2008.
19. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127: 355-360, 2011.
20. Virchow JC, Mehta A, Ljungblad L, et al. MONICA study group. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Respir Med 104: 644-651, 2010.
21. Arioka H, Kobayashi K, Kudo K. Validation of a disease-specific module, Asthma Health Questionnaire (AHQ) using Japanese adult asthmatic patients. Allergol Int 54: 473-482, 2005.
22. Currie GP, Lee DK, Srivastava P. Long-acting bronchodilator or leukotriene modifier as add-on therapy to inhaled corticosteroids in persistent asthma? Chest 128: 2954-2962, 2005.
23. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327: 891, 2003.
24. Suzuki T, Kaneko M, Saito I, et al. Comparison of physicians' compliance, clinical efficacy, and drug cost before and after introduction of Asthma Prevention and Management Guidelines in Japan (JGL2003). Allergol Int 59: 33-41, 2010.
25. Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167: 813-818, 2003.
26. Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 334: 1380-1388, 1996.
27. Sullivan P, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343: 1006-1008, 1994.